INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 46m ago
HOUSE PTR6m ago
SEC 13F6m ago
ROBINHOOD CHAIN5m ago
Public company

BNTXBioNTech SE

CIK 0001776985

EDGAR filingsOpen in network
Disclosed transactions37
Buys / sells0 / 27
Max Insider Score24
Connections7with evidence

BNTX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$3.45M
36.2K sh
Oct 9, 2026Oct 9, 2026
traded Oct 9, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Sahin UgurChief Executive Officer, 10% Owner · Sep 8, 2026
  • ← Insider ofevidence
    Zapata Gomez RamonChief Financial Officer · May 13, 2026
  • ← Insider ofevidence
    Jimenez KylieChief People Officer · May 13, 2026
15
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL
$2.49M
27.0K sh
Oct 8, 2026
Oct 9, 2026
traded Oct 8, 2026
+1d
SEC FORM 4

Evidence

15
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$2.30M
24.0K sh
Oct 7, 2026Oct 7, 2026
traded Oct 7, 2026
+0dSEC FORM 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$2.03M
21.0K sh
Oct 6, 2026Oct 6, 2026
traded Oct 6, 2026
+0dSEC FORM 4

Evidence

15
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$7.00M
72.0K sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC FORM 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$1.64M
17.0K sh
Oct 2, 2026Oct 2, 2026
traded Oct 2, 2026
+0dSEC FORM 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$1.66M
17.0K sh
Oct 1, 2026Oct 2, 2026
traded Oct 1, 2026
+1dSEC FORM 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$3.14M
32.0K sh
Sep 30, 2026Sep 30, 2026
traded Sep 30, 2026
+0dSEC FORM 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$3.34M
34.0K sh
Sep 29, 2026Sep 30, 2026
traded Sep 29, 2026
+1dSEC FORM 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$2.66M
27.0K sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC FORM 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$3.35M
34.0K sh
Sep 28, 2026Sep 28, 2026
traded Sep 28, 2026
+0dSEC FORM 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$2.98M
30.0K sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC FORM 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$3.86M
39.0K sh
Sep 24, 2026Sep 24, 2026
traded Sep 24, 2026
+0dSEC FORM 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$4.63M
46.0K sh
Sep 22, 2026Sep 22, 2026
traded Sep 22, 2026
+0dSEC FORM 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$3.23M
33.0K sh
Sep 21, 2026Sep 22, 2026
traded Sep 21, 2026
+1dSEC FORM 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$2.89M
30.0K sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC FORM 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$3.35M
34.0K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC FORM 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$3.28M
34.0K sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC FORM 4

Evidence

7
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$1.44M
15.0K sh
Sep 16, 2026Sep 16, 2026
traded Sep 16, 2026
+0dSEC FORM 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$4.08M
41.0K sh
Sep 14, 2026Sep 14, 2026
traded Sep 14, 2026
+0dSEC FORM 4

Evidence

14
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$4.36M
45.0K sh
Sep 11, 2026Sep 14, 2026
traded Sep 11, 2026
+3dSEC FORM 4

Evidence

10
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$1.97M
20.5K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

10
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$3.52M
36.0K sh
Sep 9, 2026Sep 9, 2026
traded Sep 9, 2026
+0dSEC FORM 4

Evidence

10
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$3.67M
37.0K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC FORM 4

Evidence

24
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$4.63M
45.0K sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC FORM 4

Evidence

10
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$3.26M
31.5K sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC FORM 4

Evidence

9
ZR
Zapata Gomez RamonChief Financial Officer
BNTXBioNTech SE
Grant or award
A—
15.1K sh
May 12, 2026May 13, 2026
traded May 12, 2026
+1dSEC FORM 4

Evidence

9
JK
Jimenez KylieChief People Officer
BNTXBioNTech SE
Grant or award
A—
8,391 sh
May 12, 2026May 13, 2026
traded May 12, 2026
+1dSEC FORM 4

Evidence

9
RP
Ryan James Timothy PatrickSee remarks.
BNTXBioNTech SE
Grant or award
A—
12.6K sh
May 12, 2026May 13, 2026
traded May 12, 2026
+1dSEC FORM 4

Evidence

9
RP
Ryan James Timothy PatrickSee remarks.
BNTXBioNTech SE
Grant or award
A—
10.1K sh
May 12, 2026May 13, 2026
traded May 12, 2026
+1dSEC FORM 4

Evidence

9
HA
Hanekamp AnnemarieChief Commercial Officer
BNTXBioNTech SE
Grant or award
A—
12.6K sh
May 12, 2026May 13, 2026
traded May 12, 2026
+1dSEC FORM 4

Evidence

9
HA
Hanekamp AnnemarieChief Commercial Officer
BNTXBioNTech SE
Grant or award
A—
10.1K sh
May 12, 2026May 13, 2026
traded May 12, 2026
+1dSEC FORM 4

Evidence

5
PS
Poetting SierkChief Operating Officer
BNTXBioNTech SE
Grant or award
A—
10.1K sh
May 12, 2026May 13, 2026
traded May 12, 2026
+1dSEC FORM 4

Evidence

9
JK
Jimenez KylieChief People Officer
BNTXBioNTech SE
Grant or award
A—
10.5K sh
May 12, 2026May 13, 2026
traded May 12, 2026
+1dSEC FORM 4

Evidence

9
ZR
Zapata Gomez RamonChief Financial Officer
BNTXBioNTech SE
Grant or award
A—
18.9K sh
May 12, 2026May 13, 2026
traded May 12, 2026
+1dSEC FORM 4

Evidence

5
PS
Poetting SierkChief Operating Officer
BNTXBioNTech SE
Grant or award
A—
12.6K sh
May 12, 2026May 13, 2026
traded May 12, 2026
+1dSEC FORM 4

Evidence

18
PS
Poetting SierkChief Operating Officer
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$5.53M
50.0K sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Ryan James Timothy PatrickSee remarks. · May 13, 2026
  • ← Insider ofevidence
    Hanekamp AnnemarieChief Commercial Officer · May 13, 2026
  • ← Insider ofevidence
    Poetting SierkChief Operating Officer · Apr 23, 2026